• Brugada Syndrome Multi-Gene Panel, NGS
  • Cyclin-D1 (BCL1) Expression, Immunohistochemistry, Tissue
  • HLA DQ Genotyping for Celiac Disease
  • Medium-Chain Acyl-CoA Dehydrogenase (MCAD) Mutation Analysis
  • Hydroxychloroquine, Serum
  • Serotonin Receptor HTR2A Genotyping
  • CxBladder™ (Detect, Triage, Triage Enhanced, Monitor) Bladder Cancer Test
  • Osmolality, Urine
  • Sickle Cell Screen
  • FBN1 (Fibrillin-1) Genetic Mutation Analysis
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /BCR-ABL1 Mutation Analysis for Tyrosine Kinase Inhibitor Resistance
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References

BCR-ABL1 Mutation Analysis for Tyrosine Kinase Inhibitor Resistance
Medical Test

Clinical Utility
Access to BCR-ABL1 Mutation Analysis for Tyrosine Kinase Inhibitor Resistance is restricted.
Loading...